Clinical Trials Logo

Clinical Trial Summary

Since, lowering blood pressure (BP) in elevated blood pressure individuals represents an excellent opportunity to for primary prevention of hypertension (HTN). Therefore, it is planned to use a safe treatment option - oral melatonin supplementation - associated with lifestyle interventions according to the American college of cardiology/American heart association (ACC/AHA) 2013 guideline in elevated blood pressure individuals to mitigate systolic and diastolic BP and ultimately, to prevent the development of HTN.

Hypothesis:

Melatonin therapy can lower the systolic and diastolic BP of elevated blood pressure individuals Melatonin can attenuate levels of circulatory biomarkers of Hs- CRP, Cholesterol, LDL-c and triglyceride


Clinical Trial Description

Study design: Randomized controlled trial (RCT)

Study population: Elevated blood pressure individuals who present themselves at the outpatient clinics of Tehran Heart Centre(THC) , seeking blood pressure treatment and who have a systolic blood pressure of 120-129 mmHg or a diastolic blood pressure of =80 mmHg.

Treatment groups: Melatonin 3 mg versus placebo

sample size: 160 per group ( 320 overall)

Treatment allocation: After completing informed consent and prior to randomization, all participants undergo complete physical examination and laboratory test. Baseline levels of inflammatory biomarkers and pregnancy test (for women in reproductive age) will be performed. Sleep quality, actual sleep time, and sleep latency will be recorded.

Treatment plan: Three weeks melatonin 3 Mg or placebo one hour before bedtime has been planned. All of the melatonin and placebo capsules will be supplied from a single hospital pharmacy and free of charge to the participants. Melatonin and placebo capsules will be identical. Participants will receive a three weeks supply at the assignment time. Besides, all participants will receive a careful plan of adherence to a heart-healthy diet, regular exercise, instruction for avoidance of tobacco use and maintenance of a healthy body mass index (BMI) according to 2013ACC/ AHA guideline.

Follow up: Three weeks ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03764020
Study type Interventional
Source Tehran University of Medical Sciences
Contact zinat Hatmi
Phone +982164053219
Email hatmizn@sina.tums.ac.ir
Status Not yet recruiting
Phase Phase 3
Start date January 1, 2019
Completion date January 1, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03626363 - Mindfulness and Neural Cardiovascular Control in Humans N/A
Completed NCT03716960 - The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women. N/A
Completed NCT00869193 - Effect of Grape Seed Extract on Blood Pressure N/A
Recruiting NCT03508739 - Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition Phase 3
Completed NCT02513823 - Effectiveness of Vitamin D Supplementation N/A
Completed NCT03099954 - Withings Pulse Wave Velocity and Blood Pressure Study N/A
Recruiting NCT03370991 - Blueberries for Improving Vascular Endothelial Function in Postmenopausal Women With Elevated Blood Pressure Phase 2/Phase 3